Anti-rejection drug may eliminate skin cancer

03/31/2005 | NYTimes.com

The immunosuppressive drug sirolimus also reversed a skin cancer, Kaposi's sarcoma, which afflicts kidney transplant patients, according to a study in the New England Journal of Medicine. Fifteen patients who developed cancerous skin lesions while taking other anti-rejection drugs saw the lesions disappear with three months of switching to sirolimus.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Director, Antibiotics and Innovation Project
The Pew Charitable Trusts
Washington, DC